2004
DOI: 10.1111/j.1439-0507.2004.00962.x
|View full text |Cite
|
Sign up to set email alerts
|

Pichia anomala fungaemia in immunocompromised children

Abstract: Pichia anomala is an emerging yeast causing serious nosocomial infections in newborn and immunocompromised children. We describe nosocomial port catheter infection due to P. anomala in three children who were receiving cancer chemotherapy, bloodstream infection in a preterm infant and in an infant with severe combined immunodeficiency. All patients were treated with amphotericin B. All isolates were susceptible to amphotericin B and fluconazole. No recurrence was observed during follow-up in four of five patie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(12 citation statements)
references
References 27 publications
(78 reference statements)
0
11
0
Order By: Relevance
“…As a rarely described clinical nosocomial agent, Pichia spp. are usually associated with invasive infections and fungaemia in neonates and immunosuppressed individuals [ 99 , 100 , 101 ]. Standard fungal risk factors, such as prematurity, low birth weight, long duration of hospital stay, prior use of antibiotics, intravenous catheterization, intravenous drug abuse, etc., are associated with Pichia infection [ 101 ].…”
Section: Discussionmentioning
confidence: 99%
“…As a rarely described clinical nosocomial agent, Pichia spp. are usually associated with invasive infections and fungaemia in neonates and immunosuppressed individuals [ 99 , 100 , 101 ]. Standard fungal risk factors, such as prematurity, low birth weight, long duration of hospital stay, prior use of antibiotics, intravenous catheterization, intravenous drug abuse, etc., are associated with Pichia infection [ 101 ].…”
Section: Discussionmentioning
confidence: 99%
“…It was reported that in most of the C. pelliculosa cases, removing the catheter and amphotericin-B treatment created successful results in infections (6,23). Kalkancı et al (6) reported that C. pelliculosa fungemia was successfully treated by amphotericin-B, fluconazole and removal of the catheter.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the suspension prepared Minimal inhibition concentration (MIC) sensitivity values for fluconazole (≤8 µg/mL sensitive, 16-32 µg/mL dosesensitive, ≥64 µg/mL resistant) and for voriconazole (≤1 µg/ mL sensitive, 2 µg/mL dose-sensitive, ≥4 µg/mL resistant) were implemented according to CLSI recommendations (22). MIC value for caspofungin (≤2 µg/mL sensitive) was evaluated based on the reference of a study (23). For amphotericin B (≤1 µg/mL sensitive, ≥2 µg/mL resistant) was accepted (24).…”
Section: Antifungal Sensitivity Testmentioning
confidence: 99%
“…Nosocomial infections caused by W. anomalus in adults and pediatric patients have been reported around the world with a mortality rate up to 38% and 42%, respectively [ 8 , 11 , 12 ]. The first published outbreak in PICU described five neonates with fungemia, two with fungemia and ventriculitis, and one with ventriculitis.…”
Section: Introductionmentioning
confidence: 99%